Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 123

1.

Therapeutic drug monitoring and drug-drug interactions involving antiretroviral drugs.

Boffito M, Acosta E, Burger D, Fletcher CV, Flexner C, Garaffo R, Gatti G, Kurowski M, Perno CF, Peytavin G, Regazzi M, Back D.

Antivir Ther. 2005;10(4):469-77. Review.

PMID:
16038472
[PubMed - indexed for MEDLINE]
2.

Current status and future prospects of therapeutic drug monitoring and applied clinical pharmacology in antiretroviral therapy.

Boffito M, Acosta E, Burger D, Fletcher CV, Flexner C, Garaffo R, Gatti G, Kurowski M, Perno CF, Peytavin G, Regazzi M, Back D.

Antivir Ther. 2005;10(3):375-92. Review.

PMID:
15918329
[PubMed - indexed for MEDLINE]
3.

Therapeutic drug monitoring in HIV infection: current status and future directions.

Back D, Gatti G, Fletcher C, Garaffo R, Haubrich R, Hoetelmans R, Kurowski M, Luber A, Merry C, Perno CF.

AIDS. 2002 Mar;16 Suppl 1:S5-37. Review.

PMID:
12035820
[PubMed - indexed for MEDLINE]
4.

Improving HIV infection management using antiretroviral plasma drug levels monitoring: a clinician's point of view.

Clevenbergh P, Mouly S, Sellier P, Badsi E, Cervoni J, Vincent V, Trout H, Bergmann JF.

Curr HIV Res. 2004 Oct;2(4):309-21. Review.

PMID:
15544452
[PubMed - indexed for MEDLINE]
5.

Critical issues in therapeutic drug monitoring of antiretroviral drugs.

Van Heeswijk RP.

Ther Drug Monit. 2002 Jun;24(3):323-31. Review.

PMID:
12021621
[PubMed - indexed for MEDLINE]
6.

Therapeutic drug monitoring: an aid to optimising response to antiretroviral drugs?

Aarnoutse RE, Schapiro JM, Boucher CA, Hekster YA, Burger DM.

Drugs. 2003;63(8):741-53. Review.

PMID:
12662123
[PubMed - indexed for MEDLINE]
7.

Practical guidelines to interpret plasma concentrations of antiretroviral drugs.

Kappelhoff BS, Crommentuyn KM, de Maat MM, Mulder JW, Huitema AD, Beijnen JH.

Clin Pharmacokinet. 2004;43(13):845-53. Review.

PMID:
15509183
[PubMed - indexed for MEDLINE]
8.

An update on therapeutic drug monitoring for antiretroviral drugs.

Back D, Gibbons S, Khoo S.

Ther Drug Monit. 2006 Jun;28(3):468-73. Review.

PMID:
16778736
[PubMed - indexed for MEDLINE]
9.

Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel.

Hammer SM, Eron JJ Jr, Reiss P, Schooley RT, Thompson MA, Walmsley S, Cahn P, Fischl MA, Gatell JM, Hirsch MS, Jacobsen DM, Montaner JS, Richman DD, Yeni PG, Volberding PA; International AIDS Society-USA.

JAMA. 2008 Aug 6;300(5):555-70. doi: 10.1001/jama.300.5.555.

PMID:
18677028
[PubMed - indexed for MEDLINE]
10.

Drug interactions in the management of HIV infection: an update.

Robertson SM, Penzak SR, Pau A.

Expert Opin Pharmacother. 2007 Dec;8(17):2947-63. Review.

PMID:
18001255
[PubMed - indexed for MEDLINE]
11.

Pharmacokinetic variability of antiretroviral drugs and correlation with virological outcome: 2 years of experience in routine clinical practice.

Fabbiani M, Di Giambenedetto S, Bracciale L, Bacarelli A, Ragazzoni E, Cauda R, Navarra P, De Luca A.

J Antimicrob Chemother. 2009 Jul;64(1):109-17. doi: 10.1093/jac/dkp132. Epub 2009 Apr 27.

PMID:
19398461
[PubMed - indexed for MEDLINE]
Free Article
12.

Clinical benefit of interventions driven by therapeutic drug monitoring.

Rendón A, Núñez M, Jiménez-Nácher I, González de Requena D, González-Lahoz J, Soriano V.

HIV Med. 2005 Sep;6(5):360-5.

PMID:
16156885
[PubMed - indexed for MEDLINE]
13.

[Clinical pharmacology of nucleoside and nucleotide reverse transcriptase inhibitors].

Bonora S, Calcagno A, Gonzalez de Requena D, Bargiacchi O, Di Perri G.

Infez Med. 2006 Jun;14(2):61-70. Review. Italian.

PMID:
16891850
[PubMed - indexed for MEDLINE]
Free Article
14.

Protease inhibitor plasma concentrations in HIV antiretroviral therapy.

Justesen US.

Dan Med Bull. 2008 Nov;55(4):165-85. Review.

PMID:
19232158
[PubMed - indexed for MEDLINE]
15.

Clinical pharmacology of antiretroviral therapy.

Di Perri G, Sinicco A, Audagnotto S, Gobbi F, Canta F, Marrone R, Bonora S.

New Microbiol. 2004 Apr;27(2 Suppl 1):131-4.

PMID:
15646076
[PubMed - indexed for MEDLINE]
16.

Pharmacokinetic drug interactions with non-nucleoside reverse transcriptase inhibitors.

Ma Q, Okusanya OO, Smith PF, Dicenzo R, Slish JC, Catanzaro LM, Forrest A, Morse GD.

Expert Opin Drug Metab Toxicol. 2005 Oct;1(3):473-85. Review.

PMID:
16863456
[PubMed - indexed for MEDLINE]
17.

Therapeutic drug monitoring and human immunodeficiency virus (HIV) antiretroviral therapy.

Justesen US.

Basic Clin Pharmacol Toxicol. 2006 Jan;98(1):20-31. Review.

PMID:
16433887
[PubMed - indexed for MEDLINE]
18.

Warfarin-antiretroviral interactions.

Liedtke MD, Rathbun RC.

Ann Pharmacother. 2009 Feb;43(2):322-8. doi: 10.1345/aph.1L497. Epub 2009 Feb 5. Review.

PMID:
19196837
[PubMed - indexed for MEDLINE]
19.

What's in a trough? Therapeutic drug monitoring and antiretroviral regimens.

Flexner C.

Hopkins HIV Rep. 2000 Jan;12(1):5, 12.

PMID:
11366318
[PubMed - indexed for MEDLINE]
20.

A randomized controlled trial of therapeutic drug monitoring in treatment-naive and -experienced HIV-1-infected patients.

Best BM, Goicoechea M, Witt MD, Miller L, Daar ES, Diamond C, Tilles JG, Kemper CA, Larsen R, Holland DT, Sun S, Jain S, Wagner G, Capparelli EV, McCutchan JA, Haubrich RH; California Collaborative Treatment Group 578 Study Team.

J Acquir Immune Defic Syndr. 2007 Dec 1;46(4):433-42.

PMID:
17786128
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk